Results 11 to 20 of about 4,481,490 (243)

Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism

Journal of the Endocrine Society, 2020
Purpose Normal basal plasma aldosterone concentration (PAC) reflects mild aldosterone excess compared to high basal PAC. We previously reported lower risk for cardiovascular and cerebrovascular events in patients with primary aldosteronism (PA) and ...
A. Saiki, M. Otsuki, K. Mukai, Reiko D. Hayashi, I. Shimomura, I. Kurihara, T. Ichijo, Y. Takeda, T. Katabami, M. Tsuiki, N. Wada, Y. Ogawa, J. Kawashima, M. Sone, N. Inagaki, T. Yoshimoto, R. Okamoto, Katsutoshi Takahashi, H. Kobayashi, K. Tamura, K. Kamemura, Koichi Yamamoto, Shoichiro Izawa, M. Kakutani, M. Yamada, A. Tanabe, M. Naruse   +26 more
semanticscholar   +3 more sources

Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. [PDF]

Journal of Clinical Investigation, 1973
Plasma aldosterone, cortisol, and renin activity were measured in nine recumbent patients with hyperaldosteronism, including seven with adenomas, one with idiopathic hyperplasia, and one with glucocorticoid suppressible hyperplasia. All had peak values of plasma aldosterone concentration from 3 a.m. to noon and lowest values at 6 p.m. or midnight. This
D. Kem, Myron H. Weinberger, C. Gomez-Sanchez, N. Kramer, R. Lerman, S. Furuyama, C. A. Nugent   +6 more
semanticscholar   +3 more sources

Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism [PDF]

Journal of the Endocrine Society, 2018
Context The involvement of visceral fat in aldosterone secretion has not been reported in patients with primary aldosteronism (PA). Patients with PA are complicated by metabolic syndrome more frequently than those without PA.
Y. Shibayama, N. Wada, Shuhei Baba, Y. Miyano, Shinji Obara, Ren Iwasaki, Haruka Nakajima, Hidetsugu Sakai, H. Usubuchi, S. Terae, A. Nakamura, T. Atsumi   +11 more
semanticscholar   +3 more sources

Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening [PDF]

International Journal of Endocrinology, 2018
Aim This retrospective study is aimed at investigating whether aldosterone-renin ratio (ARR) cutoffs calculated by the plasma aldosterone concentration (PAC)/plasma renin concentration (PRC) should be set differently in patients of different ages ...
Lin-Qiang Ma, Ying Song, M. Mei, Wen-Wen He, Jin-Bo Hu, Qing-Feng Cheng, Zi-Wei Tang, Ting Luo, Yue Wang, Qian-Na Zhen, Zhi-Hong Wang, Hua Qing, Yi-Hong He, Qi-Fu Li, Shu-Min Yang   +14 more
semanticscholar   +4 more sources

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. [PDF]

European Journal of Endocrinology, 2019
OBJECTIVE Several clinical studies have reported that renal impairments are sometimes observed in patients with primary aldosteronism (PA). We analyzed the prevalence of renal impairments in PA patients and identified parameters that increase the risk ...
A. Kawashima, M. Sone, N. Inagaki, Y. Takeda, H. Itoh, I. Kurihara, H. Umakoshi, T. Ichijo, T. Katabami, N. Wada, Y. Ogawa, J. Kawashima, M. Fujita, S. Miyauchi, Shintaro Okamura, Tomikazu Fukuoka, T. Yanase, Shoichiro Izawa, Yuichiro Yoshikawa, Shigeatsu Hashimoto, M. Yamada, T. Kai, Tomoko Suzuki, M. Naruse, _   +24 more
semanticscholar   +3 more sources

Effect of Anti-Hypertensive Medication on Plasma Concentrations of Lysyl Oxidase: Evidence for Aldosterone-IL-6-Dependent Regulation of Lysyl Oxidase Blood Concentration [PDF]

Biomedicines, 2022
Lysyl oxidase (LOX) is a secretory protein that catalyzes elastin and collagen cross-linking. Lowering LOX expression and activity in endothelial cells is associated with a high risk of aneurysms and vascular malformation.
Rolf Schreckenberg, Oliver Dörr, Sabine Pankuweit, Bernhard Schieffer, Christian Troidl, Holger Nef, Christian W. Hamm, Susanne Rohrbach, Ling Li, Klaus-Dieter Schlüter   +9 more
doaj   +2 more sources

Associating Plasma Aldosterone Concentration With the Prevalence of MAFLD in Hypertensive Patients: Insights From a Large-Scale Cross-Sectional Study

Frontiers in Endocrinology
Objective To explore the link between plasma aldosterone concentration (PAC) and the prevalence of metabolic dysfunction-related fatty liver disease (MAFLD) in hypertensive patients. Methods We analyzed data from 41,131 hospitalized patients from January
Delian Zhang, Jing Hong, Junli Hu
exaly   +2 more sources

Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography–tandem mass spectrometry determinations of plasma aldosterone concentration

Journal of Hypertension, 2018
Background: Primary aldosteronism is affecting about 10% of hypertensive patients. Primary aldosteronism should be diagnosed by screening tests based on plasma aldosterone concentration (PAC) and aldosterone-to-renin ratio (ARR), followed by confirmatory
S. Baron, L. Amar, Anne-Laure Faucon, A. Blanchard, Laurence Baffalie, Catherine Faucard, Simon Travers, J. Pagny, M. Azizi, P. Houillier   +9 more
semanticscholar   +2 more sources

Plasma aldosterone concentration at delivery and during the newborn period. [PDF]

Journal of Clinical Investigation, 1972
Aldosterone concentrations in plasma of women on normal sodium intake undergoing cesarean section were 3.7+/-1.4 ng/100 ml (mean+/-1 SD). These values were significantly lower (P < 0.001) than those observed in mothers on normal sodium diet, delivered by the vaginal route (14.9+/-7.0 ng/100 ml). A significant elevation (P < 0.001) of the concentrations
I. Beitins, F. Bayard, L. Levitsky, I. Ances, A. Kowarski, C. Migeon   +5 more
semanticscholar   +3 more sources

Plasma Aldosterone Concentrations Elevation in Hypertensive Patients: The Dual Impact on Hyperuricemia and Gout

Frontiers in Endocrinology
Background Prior research has highlighted the association between uric acid (UA) and the activation of the renin-angiotensin-aldosterone system (RAAS).
Delian Zhang, Jing Hong, Junli Hu
exaly   +2 more sources